default author photo

Munyaradzi Musvosvi

University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative

SCHOLARLY PAPERS

2

DOWNLOADS

207

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Subclinical Tuberculosis in Children with Household Exposure to Mycobacterium Tuberculosis: A Prospective Cohort Study

Number of pages: 16 Posted: 26 Sep 2024
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stanford University - Division of Infectious Diseases and Geographic Medicine, University of Washington - Department of Global Health, Colorado State University, Fort Collins - Arthropod-Borne and Infectious Diseases Laboratory, The Translational Genomics Research Institute (TGen), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 120 (604,538)

Abstract:

Loading...

Tuberculosis, TB, subclinical, child, household

2.

Prospective Validation of a Host Blood Transcriptomic Biomarker for Pulmonary Tuberculosis in People Living with HIV: A Diagnostic and Prognostic Accuracy Study

Number of pages: 54 Posted: 25 Jan 2021
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Foundation for Innovative New Diagnostics (FIND), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Fred Hutchinson Cancer Research Center, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, London School of Hygiene & Tropical Medicine, London School of Hygiene & Tropical Medicine, The Aurum Institute, Aurum Institute for Health Research, Stellenbosch University, Stellenbosch University, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University - Division of Molecular Biology and Human Genetics, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA)University of the Witwatersrand - South African Medical Research Council, Aurum Institute, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and Independent
Downloads 87 (765,566)

Abstract:

Loading...